Aim-To survey the use made of laboratory services for urgent tests and clinicians' attitudes to near patient testing. Methods-A questionnaire was sent to clinicians working in acute hospitals within Trent and North West Thames Regions. It is over 10 years since Marks suggested that advances in the technology of near patient testing may bring biochemistry nearer the patient,"2 but it is only in the past few years that the technology has become sufficiently advanced for that to be true for more than one or two tests, such as blood glucose and gases. Companies are now marketing a much wider range of bedside tests not just in biochemistry but also for most other pathology disciplines, which could previously only be undertaken in the hospital laboratory. At the same time, hospitals are coming under increasing pressure to shorten patients' stay and are looking for ways of obtaining pathology test results more rapidly to reduce delays between diagnosis and treatment. The reduction in junior doctors' hours also creates pressure for a more rapid turnround of pathology results as junior medical staff have to cover more patients in order to deliver care within their hours and have less time to follow up on requests to the laboratory as they tend to have more fragmented contact with patients. These pressures are creating renewed interest in near patient testing and rapid sample transport as strategies to decrease turnround time for pathology tests. Some hospitals have introduced the concept of patient focused care3 which involves, among other changes, the use of multi-skilled staff to reduce the number involved in delivering direct patient care. By operating bedside testing on a patient focused unit, such staff may be able to provide pathology results more directly and rapidly. However, the demand for near patient testing from hospital clinicians has not been quantified and it is not clear whether a wholesale move towards ward based testing would be welcomed. A working party of the Standing Advisory Committee in Chemical Pathology of the Royal College of Pathologists was set up to examine this question. The Committee undertook to survey the demand for urgent laboratory tests and explore clinicians' views of near patient testing. 
replies were received. Most demand came from intensive care units. Overall, clinicians requested a median of six urgent tests a day. Blood glucose and dip stick urine testing were the most commonly performed bedside tests, but 41% of clinicians did not use ward testing. The most frequently cited indication for bedside testing was the need for speed. 85% of clinicians trusted results obtained in their central hospital laboratory, but there was an almost equal division between those who did (34%) and those who did not (38%) trust the results from near patient testing. A slightly larger proportion indicated they would accept responsibility (44%) for results obtained on the ward than would not (35%). Most staff indicated that better transport to the laboratory would remove the need for near patient testing. Conclusions-Clinicians have demonstrated an apparent need for rapid response testing but there is a strong preference for rapid transport systems and central laboratory analysis rather than bedside testing as a solution to this problem. There is a need to investigate the clinical and cost-effectiveness of near patient testing as a solution to rapid response testing. (7 Clin Pathol 1996; 49:903-908) Keywords: near patient testing, rapid response testing, survey.
It is over 10 years since Marks suggested that advances in the technology of near patient testing may bring biochemistry nearer the patient,"2 but it is only in the past few years that the technology has become sufficiently advanced for that to be true for more than one or two tests, such as blood glucose and gases. Companies are now marketing a much wider range of bedside tests not just in biochemistry but also for most other pathology disciplines, which could previously only be undertaken in the hospital laboratory. At the same time, hospitals are coming under increasing pressure to shorten patients' stay and are looking for ways of obtaining pathology test results more rapidly to reduce delays between diagnosis and treatment. The reduction in junior doctors' hours also creates pressure for a more rapid turnround of pathology results as junior medical staff have to cover more patients in order to deliver care within their hours and have less time to follow up on requests to the laboratory as they tend to have more fragmented contact with patients. These pressures are creating renewed interest in near patient testing and rapid sample transport as strategies to decrease turnround time for pathology tests. Some hospitals have introduced the concept of patient focused care3 which involves, among other changes, the use of multi-skilled staff to reduce the number involved in delivering direct patient care. By operating bedside testing on a patient focused unit, such staff may be able to provide pathology results more directly and rapidly. However, the demand for near patient testing from hospital clinicians has not Junior hospital Doctors should be looking after patients not doing laboratory Tests which were not available at some sites but which were required urgently from the laboratory by more than one respondent are given in table 2. Other tests listed singly which consultants considered would be useful included sickle tests, chloride, fine needle aspirations cytology, HIV tests, urine protein, myoglobin, oestradiol, prostate specific antigen, urea, sputum microscopy, and the Kleihauer test.
NEAR PATIENT TESTS
The most commonly performed ward test was blood glucose (43% of replies, with a median of eight requests daily), and ward urine testing (26% of replies, with a median of six ward tests daily). Ward based testing was skewed in the same way as urgent requests to the laboratory; 41% of replies indicated that consultants did not use ward testing. At the other end of the scale, one neonatal unit, in a hospital with an off site laboratory, estimated that over 200 requests were performed on the wards, mainly blood glucose and blood gas measurements. Table 3 indicates the tests that were reported as being carried out on the wards by more than one respondent. Up to 3% of consultants felt results phoned to them, rather than have to look them up on a computer screen. There was some support for near patient testing in the intensive care units or for a "hot" laboratory facility next to these units. This concept received support particularly from the clinicians working in intensive care, although some suggested that it was only necessary to have a blood gas analyser on the ward with all other analyses being performed remotely in the main laboratory linked by a tube transport system.
SAMPLE TRANSPORT
Sample transport to the laboratories was clearly identified as a problem in obtaining a rapid response. Sixteen (59%) hospitals either possessed tube transport systems or were installing one. In most cases these were linked to only a few sites in the hospital but a few had more comprehensive systems linking the acute areas and the laboratories. Unsolicited comments from those without such systems revealed the considerable amount of frustration for laboratory and clinical staff generated by the problems of getting samples to the laboratory quickly. On the main questionnaire, the statement suggesting that a good laboratory response eliminated the need for near patient testing was echoed in many of the final comments; however, there were many references to the difficulties junior staff found in contacting the laboratory or getting the sample there.
Discussion
These results support the evidence from Pathology laboratories throughout the country that there is considerable demand for urgent tests from acute clinical areas. Figures for the department of clinical chemistry from the pilot hospital showed that demand represents up to 20% of the laboratory workload on some days. In this survey, clinicians requesting very large numbers of tests per day tended to work in acute ward areas (for example, estimates of 100 blood gases per day from a large intensive care unit and 100 blood glucose estimations a day from a diabetic inpatient ward). Nevertheless, the median figures accord with the experience of laboratories receiving these requests.
There is no doubt about the place of near patient testing in some settings such as the intensive care unit where information from blood gas analysis is used in adjusting ventilator settings, or diabetic wards where blood glucose measurements are essential in monitoring diabetics. Indeed, in this survey, the largest demand came from intensive care, neonatal care and diabetic wards. However, there is no evidence that near patient testing provides positive patient benefits when compared with sending samples for rapid central laboratory analysis. One study from America indicated that patient outcomes may be worse if analyses of critical tests are performed by physicians' office laboratories performing few tests on a regular basis rather than central laboratories. 4 Even in the accident and emergency department where near patient testing might be expected to have an impact, this has not been borne out by detailed study.5 Most clinicians cited the need for speed as their reason for using bedside testing, but no attempt was made in this questionnaire to ask them to justify their need for urgency for the wide range of tests mentioned. Surprisingly, patient management did not figure prominently in the reasons given. Despite this, consultants were cautious about using the results of near patient testing for patient management, even if they can be obtained quickly, where as the most positive statement by all respondents was that they trusted their local laboratory results. Indeed, 44% would not accept responsibility for a near patient test result. The latter point suggests that there is a need to define clearly the line of accountability for near patient testing.
The concern shown by a significant number of clinicians in this survey about the quality of the results of near patient testing is justified.
Two hazard warnings have been issued about near patient testing equipment,67 drawing attention to the need for adequate management supervision and quality control procedures when operating such equipment. A study8 undertaken in 1986 in one of the regions surveyed revealed that quality control procedures and training of users were undertaken in connection with fewer than 50% of sites with blood gas analysers and 25% of sites with blood glucose meters. The situation had improved considerably in 19939 and currently 100% of laboratories are involved with near patient testing instruments in that region (D Freedman, personal communication) . This situation is not universal, however, as a national survey of intensive care facilities showed that nearly half of the units did not consult their biochemistry department regarding equipment choice or methodology, and 30% of intensive care laboratories performed no quality control.'°In this survey, although 46% believed their staff were appropriately trained for near patient testing, 37% did not know and significantly fewer (24%) thought their performance was monitored regularly, an essential part of quality assurance.
Quality assurance of central laboratory analytical services is now being tested by laboratory accreditation." This covers all aspects of the laboratory service including management, staff training, procedures and protocols, health and safety, as well as formal quality assessment procedures. In principle, quality assurance of near patient testing should follow the same standards, in that staff should be trained to perform the tests, operating and reporting procedures should be documented and followed, and there should be a regular programme of internal and external quality assurance. A number of codes of practice have been drawn up to provide guidance.'2"-6 A key feature of these codes of practice is the commitment to training, monitoring and continuing education of all operators, regular quality assurance programmes and limitation on usage to certified operators. These operational issues affect many staff groups and this should be reflected in a coherent management stance on near patient testing across the hospital. '7 Providing appropriate near patient testing does cost more than the simple cost of test strips or other consumables and may be comparable with or more expensive than using central laboratories.,'-There are currently no data as to whether near patient testing is costeffective in hospitals, although in general practice where there are inevitably considerable delays in obtaining laboratory results from hospital tests, one major study showed that even here, near patient testing was only cost-effective for screening for urinary tract infection.2'
The main frustration in obtaining a rapid result for both the clinicians and laboratories was in the transport of samples to the laboratory. Although most hospitals had a tube transport system, this was not comprehensive in most of them. Demand for near patient tests may be a response to this transport problem and reflect the lack of investment in hospital infrastructure. Of staff who expressed a preference, 71 % indicated they would not need near patient testing if rapid transport were available, 79% saying that this was the biggest problem with urgent tests. This indicates a strong preference among clinicians for rapid transport systems and central laboratory analysis rather than bedside testing. The Audit Commission in its report, Critical Path,22 drew similar conclusions with respect to pathology services as a whole, identifying sample transport and report delivery as major deficiencies, often being outside the control of the laboratory. The weakness of near patient testing as a solution to this problem is highlighted by the Standing Group on Health Technology which identified near patient testing as one of the early projects in its assessment programme.23
Our study clearly confirms the apparent need for rapid response testing but poses many questions with regard to the clinical and cost-effectiveness of a near patient testing solution. Our study identifies the need for the investigation of a wide range of issues related to near patient testing; these include: * The cost-effectiveness of full quality assurance programmes for ward based testing which will include determination of the true costs of quality control and operator training, certification and continuing education. * The clinical and cost-effectiveness of rapid response testing for a range of analyses-for example, urea and electrolytes, blood gases, lactate, therapeutic drugs, blood glucose, in clinical areas such as accident and emergency, intensive care and neonatal intensive care, general medical wards and specialist outpatient clinics. * Identification of response times in relation to clinical need and the comparative value and costs for rapid sample transport and near patient testing. Finally, while this study has raised several important questions regarding the need for rapid response testing and highlighted to the absence of evidence in support of its clinical and cost-effectiveness, it has not addressed the wider issues that may influence the successful exploitation of near patient testing. The rapid availability of results is only of real value if action is taken immediately. Such action may involve institution of a particular therapeutic strategy which has clinical or operational benefit-for example, prompt a further investigation, the discharge of the patient, or initiation of a particular treatment. The effort involved in obtaining a rapid result is wasted if the result is not seen and acted on promptly.
